Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
0.562
+0.002 (0.32%)
Aug 30, 2024, 3:47 PM EDT - Market closed
Arch Therapeutics Employees
Arch Therapeutics had 8 employees as of September 30, 2023. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$18,520
Profits / Employee
-$1,624,084
Market Cap
2.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ARTH News
- 4 months ago - Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring) - GlobeNewsWire
- 10 months ago - Arch Therapeutics Provides Year End Operational Update - GlobeNewsWire
- 10 months ago - Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall) - GlobeNewsWire
- 1 year ago - Arch Therapeutics Provides AC5® Commercialization Update - GlobeNewsWire
- 1 year ago - Arch Therapeutics Completes Financing as Bridge to Uplisting - GlobeNewsWire
- 1 year ago - Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”) - GlobeNewsWire
- 1 year ago - Dedicated HCPCS Billing Code for Arch Therapeutics' AC5® Advanced Wound System Now In Effect - GlobeNewsWire
- 1 year ago - Arch Therapeutics' AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services - GlobeNewsWire